Caption Management, LLC Crispr Therapeutics Ag Put Options Transaction History

Caption Management, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $12.3 Million - $16.4 Million	-240,000 Reduced 81.36%	55,000 $2.97 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $6.37 Million - $9.36 Million	-105,000 Reduced 26.25%	295,000 $20.1 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $14.3 Million - $26.7 Million	370,000 Added 1233.33%	400,000 $25 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $6.35 Million - $8.26 Million	-140,000 Reduced 82.35%	30,000 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $7.39 Million - $11.5 Million	170,000 New	170,000 $9.54 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $265,950 - $396,200	5,000 Added 33.33%	20,000 $1.26 Million
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $1.05 Million - $1.67 Million	15,000 New	15,000 $1.14 Million
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $4.63 Million - $6.58 Million	-42,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $4.24 Million - $6.8 Million	42,000 New	42,000 $6.8 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $10.2 Million - $13.1 Million	-130,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $5.01 Million - $9.89 Million	130,000 New	130,000 $9.55 Million

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.19B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.